Antineoplastic agents 430. Isolation and structure of cribrostatins 3, 4, and 5 from the Republic of Maldives Cribrochalina species

Journal of Natural Products

Volumn 63, Issue 6, 2000, Pages 793-798

  Pettit, George R ^a   Knight, John C ^a   Collins, Jeremiah C ^a   Herald, Delbert L ^a   Pettit, Robin K ^a   Boyd, Michael R ^b   Young, Victor G ^c  

^a ARIZONA STATE UNIVERSITY   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRIBROSTATIN 3; CRIBROSTATIN 4; CRIBROSTATIN 5; PYRIDINE DERIVATIVE; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ANTIFUNGAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; CRYSTAL STRUCTURE; DRUG ISOLATION; DRUG STRUCTURE; PROTON NUCLEAR MAGNETIC RESONANCE; SPONGE (PORIFERA); X RAY CRYSTALLOGRAPHY;

ANIMALS; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CRYSTALLOGRAPHY, X-RAY; HUMANS; INDIAN OCEAN ISLANDS; ISOQUINOLINES; MAGNETIC RESONANCE SPECTROSCOPY; MICROBIAL SENSITIVITY TESTS; MODELS, MOLECULAR; PORIFERA; TUMOR CELLS, CULTURED;

CRIBROCHALINA; PORIFERA;

EID: 0033945101     PISSN: 01633864     EISSN: None     Source Type: Journal    
DOI: 10.1021/np990618q     Document Type: Article

References (40)

1. Contribution 429: Pettit, G. R.; Lippert, J. W., III; Pettit, R. K. AntiCancer Drug Design, submitted.
2. Pettit, G. R.; Collins, J. C.; Herald, D. L.; Doubek, D. L.; Boyd, M. R.; Schmidt, J. M.; Hooper, J. N. A.; Tackett, L. P. Can. J. Chem. 1992, 70, 1170-1175.
3. Nakahara, S.; Numata, R.; Tanaka, Y.; Kubo, A. Heterocycles 1995, 41, 651-654.
4. (a) Aiello, A.; Fattorusso, E.; Menna, M.; Pansini, M. J. Nat. Prod. 1992, 55, 1275-1280.
5. (b) Kulkarni, B. A.; Chattopadhyay, A.; Mamdapur, V. R. Collect. Czech. Chem. Commun. 1993, 58, 1711-1713.
6. (c) Kulkarni, B. A.; Chattopadhyay, S.; Chattopadhyay, A.; Mamdapur, V. R. J. Org. Chem. 1993, 58, 5964-5966.
7. (d) Hallock Y. F.; Cardellina, J. H., II; Balaschak, M. S.; Alexander, M. R.; Prather, T. R.; Shoemaker, R. H.; Boyd, M. R. J. Nat. Prod. 1995, 58, 1801-1807.
8. (e) Dai, J.-R.; Hallock, Y. F.; Cardellina, J. H., II; Boyd, M. R. J. Nat. Prod. 1996, 59, 88-89.
9. (f) Ohtani, T.; Kikuchi, K.; Kamezawa, M.; Hamatani, H.; Tachibana, J.; Totani, T.; Naoshima, Y. J. Chem. Soc., Perkin Trans. 1 1996, 10, 961-962.
10. (a) Matsunaga, S.; Shinoda, K.; Fusetani, N. Tetrahedron Lett. 1993, 34, 5953-5954.
11. (b) Crews, P.; Cheng, X.-C.; Adamczeski, M.; Rodriguez, J.; Jaspars, M.; Schmitz, F. J.; Traeger, S. C.; Pordesimo, E. O. Tetrahedron 1994, 50, 13567-13574.
12. (a) Nakao, Y.; Yeung, B. K. S.; Yoshida, W. Y.; Scheuer, P.; Kelly-Borges, M. J. Am. Chem. Soc. 1995, 117, 8271-8272.
13. (b) Yeung, B. K. S.; Nakao, Y.; Kinnel, R. B.; Carney, J. R.; Yoshida, W. Y.; Scheuer, P. J.; Kelly-Borges, M. J. Org. Chem. 1996, 61, 7168-7173.
14. Yeung, B. K. S.; Hamann, M. T.; Scheuer, P. J.; Kelly-Borges, M. Tetrahedron 1994, 50, 12593-12598.
15. Giner, J. L.; Djerassi, C. Steroids 1992, 57, 258-261.
16. (a) Schaufelberger, D. E.; Pettit, G. R. J. Liq. Chromatogr. 1989, 12, 1909-1917.
17. (b) Pettit, G. R.; Kamano, Y.; Schaufelberger, D. E.; Herald, C. L.; Blumberg, P. M.; May, S. W. J. Liq. Chromatogr. 1989 12, 553-561.
18. (a) Davidson, B. S. Tetrahedron Lett. 1992, 33, 3721-3724.
19. (b) He, H. Y.; Faulkner, J. D. J. Org. Chem. 1989, 54, 5822-5824.
20. (c) Frincke, J. M.; Faulkner, D. J. J. Am. Chem. Soc. 1982, 104, 265-269.
21. SHELXTL-Version 5.1 1997@, an integrated suite of programs for the determination of crystal structures from diffraction data, is available from Bruker AXS, Inc., Madison, WI 53719. This package includes, among others, XPREP (an automatic space group determination program), SHELXS (a structure solution program via Patterson or direct methods), and SHELXL (structure refinement software).
22. Flack, H. D. Acta Crystallogr. 1983, A39, 876-881.
23. (b) Flack, H. D., Schwarzenbach, D Acta Crystallogr. 1988, A44, 499-506.
24. (a) Pospiech, A.; Bietenhader, J.; Schupp, T. Microbiology 1996, 142, 741-746.
25. (b) Kubo, A.; Nakai, T.; Koizumi, Y.; Kitahara, Y.; Saito, N.; Mikami, Y.; Yazawa, K.; Uno, J. Heterocycles 1996, 42, 195-211.
26. Saito, N.; Harada, S.; Nishida, M.; Inouye, I.; Kubo, A. Chem. Pharm. Bull. 1995, 43, 777-782.
27. Cooper, R.; Unger, S. J. Antibiotics 1985, 38, 24-30.
28. (e) Arai, T.; Takahashi, K.; Nakahara, S.; Kubo, A. Experientia 1980, 36, 1025-1027.
29. (f) Arai, T.; Takahashi, K.; Kubo, A.; Nakahara, S.; Sato, S.; Tamura, C. Tetrahedron Lett. 1979, 25, 2355-2358.
30. (a) Valoti, G.; Nicoletti, M. I.; Pellegrino, A.; Jimeno, J.; Hendriks, H.; D'Incalci, M.; Faircloth, G.; Giavazzi, R. Clin. Cancer Res. 1998, 4, 1977-1983.
31. (b) Moore, B. M., II; Seaman, F. C.; Wheelhouse, R. T.; Hurley L. H. J. Am. Chem. Soc. 1998, 120, 2490-2491.
32. (c) Corey, E. J.; Gin, D. Y.; Kania, R. S. J. Am. Chem. Soc. 1996, 118, 9202-9203.
33. (d) Rinehart, K. L.; Holt, T. G.; Fregeau, N. L.; Stroh, J. G.; Keifer, P. A.; Sun, F.; Li, L. H.; Martin, D. G. J. Org. Chem. 1990, 55, 4512-4515.
34. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Susceptibility Tests; 6th ed.: approved standard M2-A6. National Committee for Clinical Laboratory Standards: Wayne, PA, 1997.
35. Fukumi, H.; Kurihara, H.; Hata, T.; Tamura, C.; Mishima, H.; Kubo, A.; Arai, T. Tetrahedron Lett. 1977, 43, 3825-3828.
36. North, A. C.; Phillips, D. C.; Matthews, F. S. Acta Crystallogr. 1968, A24, 351-359.
37. Blessing, R. Acta Crystallogr. 1995, A51, 33-38.
38. (a) McIntyre, D. E.; Faulkner, D. J.; Van Engen, D.; Clardy, J. Tetrahedron Lett. 1979, 43, 4163-4166.
39. (b) Kubo, A.; Namahara, S. J. Am. Chem. Soc. 1981, 29, 595-596.
40. Kubo, A.; Nakahara, S.; Inaba, K.; Kitahara, Y. Can. Pharm. Bull. 1986, 34, 4056-4068.